Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07673380 · ClinicalTrials.gov registry record · Phase 2
Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
A Phase 2 study, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT07673380 is a Phase 2 study that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 300 participants.
The verdict
NCT07673380, a Phase 2 study, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.
Interventions
- BEHAVIORAL uMAT-R + enhanced community engagement
- BEHAVIORAL Original uMAT-R supplementary mHealth recovery intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-08-31 |
| Est. Completion | 2027-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07673380
The ClinicalTrials.gov registry entry for NCT07673380 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which uMAT-R + enhanced community engagement is the first listed.
NCT07673380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07673380 about?
NCT07673380 is a clinical study titled "Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City". The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other for...
What is the current status of trial NCT07673380?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2025-08-31. Estimated completion is 2027-02-28.
What interventions are being tested in trial NCT07673380?
The interventions under investigation include: uMAT-R + enhanced community engagement (BEHAVIORAL), Original uMAT-R supplementary mHealth recovery intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07673380?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.